Take chimeric antigen receptor (CAR) T-cell therapy and other cell therapy programs to the next level with tailored analytical solutions that provide actionable answers.
Evaluate lentiviral vectors and lipid nanoparticles for gene editing and understand proteome changes with a collaborative team of experts.